Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
BMC Cardiovascular Disorders|June 20, 2024
The abnormalities of free fatty acid metabolism in patients with hypertrophic cardiomyopathy, a single-center retrospective observational studyKe Zhang, Zhongyu Yuan, Shengwei Wang, et al.
Endocrine-Related Cancer|January 21, 2020
The prognostic value of androgen receptor (AR) in HER2-enriched metastatic breast cancerXinyue Wang, Xiwen Bi, Zhangzan Huang, et al.
Breast Cancer Research : BCR|October 25, 2014
Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signalingXinghua Li, Weijiang Liang, Junling Liu, et al.
Annals of Translational Medicine|June 20, 2022
New classification for advanced breast cancer patients experiencing disease progression during salvage treatment: a single-center retrospective cohort studyJiahuai Wen, Liping Ren, Wenxia Li, et al.
Breast Care (Basel, Switzerland)|October 30, 2023
Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast CancerNiJiati AiErken, Nan Shao, Yuhong Liu, et al.
BMC Cardiovascular Disorders|December 16, 2022
Sex differences involved in persistent atrial fibrillation recurrence after radiofrequency ablationHaiwei Li, Zefeng Wang, Zichao Cheng, et al.
Medical Oncology (Northwood, London, England)|January 26, 2011
EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarrayDonggen Liu, Jiehua He, Zhongyu Yuan, et al.
Breast (Edinburgh, Scotland)|August 17, 2011
Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: a retrospective matched case-control studyRoujun Peng, Shusen Wang, Yanxia Shi, et al.
Medical Oncology (Northwood, London, England)|January 26, 2011
Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarrayJiehua He, Roujun Peng, Zhongyu Yuan, et al.
Oncotargets and Therapy|May 1, 2013
HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patientsTao Qin, Zhongyu Yuan, Roujun Peng, et al.
Pageof 11